Cargando…

Reduced Efficacy of d-Amphetamine and 3,4-Methylenedioxymethamphetamine in Inducing Hyperactivity in Mice Lacking the Postsynaptic Scaffolding Protein SHANK1

Genetic defects in the three SH3 and multiple ankyrin repeat domains (SHANK) genes (SHANK1, SHANK2, and SHANK3) are associated with multiple major neuropsychiatric disorders, including autism spectrum disorder (ASD), schizophrenia (SCZ), and bipolar disorder (BPD). Psychostimulant-induced hyperactiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sungur, A. Özge, Redecker, Tobias M., Andres, Elena, Dürichen, Wiebke, Schwarting, Rainer K. W., del Rey, Adriana, Wöhr, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250831/ https://www.ncbi.nlm.nih.gov/pubmed/30505269 http://dx.doi.org/10.3389/fnmol.2018.00419

Ejemplares similares

Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism
por: Filice, Federica, et al.
Publicado: (2016)

Differential Distribution of Shank and GKAP at the Postsynaptic Density
por: Tao-Cheng, Jung-Hwa, et al.
Publicado: (2015)

Environmental and Pharmacological Modulation of Amphetamine-Induced 50-kHz Ultrasonic Vocalizations in Rats
por: Rippberger, Henrike, et al.
Publicado: (2015)

3,4-methylenedioxymethamphetamine (MDMA): current perspectives
por: Meyer, Jerrold S
Publicado: (2013)

Expression of the Excitatory Postsynaptic Scaffolding Protein, Shank3, in Human Brain: Effect of Age and Alzheimer’s Disease
por: Wan, Lily, et al.
Publicado: (2021)

3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
por: Young, M B, et al.
Publicado: (2015)

Zinc Stabilizes Shank3 at the Postsynaptic Density of Hippocampal Synapses
por: Tao-Cheng, Jung-Hwa, et al.
Publicado: (2016)

Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat
por: Martins, João, et al.
Publicado: (2011)

Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms
por: McCann, Una D., et al.
Publicado: (2007)

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019)

The Effects of 3,4-methylenedioxymethamphetamine on Neurogenesis in the Hippocampus of Male Rats
por: Soleimani Asl, Sara, et al.
Publicado: (2020)

Communication Impairments in Mice Lacking Shank1: Reduced Levels of Ultrasonic Vocalizations and Scent Marking Behavior
por: Wöhr, Markus, et al.
Publicado: (2011)

Neuronal reorganization in adult rats neonatally exposed to (±)-3,4-methylenedioxymethamphetamine
por: Williams, Michael T., et al.
Publicado: (2014)

A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
por: Capela, João Paulo, et al.
Publicado: (2022)

Zingiber Officinale Alters 3,4-methylenedioxymethamphetamine-Induced Neurotoxicity in Rat Brain
por: Mehdizadeh, Mehdi, et al.
Publicado: (2012)

Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
por: Wunderli, Michael D, et al.
Publicado: (2017)

The effect of 3,4- methylenedioxymethamphetamine on expression of neurotrophic factors in hippocampus of male rats
por: Soleimani Asl, Sara, et al.
Publicado: (2017)

Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist’s Perspective
por: Sessa, Ben
Publicado: (2017)

Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy
por: Oeri, Hans Emanuel
Publicado: (2020)

3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review
por: Inouye, Ann, et al.
Publicado: (2022)

Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review
por: Fonseka, Lakshan N, et al.
Publicado: (2023)

Targeting of δ-catenin to postsynaptic sites through interaction with the Shank3 N-terminus
por: Hassani Nia, Fatemeh, et al.
Publicado: (2020)

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings
por: Baumann, Michael H., et al.
Publicado: (2006)

The influence of the host microbiome on 3,4-methylenedioxymethamphetamine (MDMA)-induced hyperthermia and vice versa
por: Ridge, Emily A., et al.
Publicado: (2019)

nArgBP2-SAPAP-SHANK, the core postsynaptic triad associated with psychiatric disorders
por: Lee, Sang-Eun, et al.
Publicado: (2018)

Methylenedioxymethamphetamine-induced toxic valvulopathy
por: Sol, Bastiaan, et al.
Publicado: (2020)

Fear Extinction and Predictive Trait-Like Inter-Individual Differences in Rats Lacking the Serotonin Transporter
por: Willadsen, Maria, et al.
Publicado: (2021)

Autophagy Activation Is Involved in 3,4-Methylenedioxymethamphetamine (‘Ecstasy’)—Induced Neurotoxicity in Cultured Cortical Neurons
por: Li, I-Hsun, et al.
Publicado: (2014)

Toxicity of the 3,4-Methylenedioxymethamphetamine and Its Enantiomers to Daphnia magna after Isolation by Semipreparative Chromatography
por: Costa, Ana Rita, et al.
Publicado: (2023)

Shank Proteins Couple the Endocytic Zone to the Postsynaptic Density to Control Trafficking and Signaling of Metabotropic Glutamate Receptor 5
por: Scheefhals, Nicky, et al.
Publicado: (2019)

Effects of Repeated Administration of 3,4-methylenedioxymethamphetamine (MDMA) on Avoidance Memory and Cell Density in Rats’ Hippocampus
por: Jahanshahi, Mehrdad, et al.
Publicado: (2013)

Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy
por: Kamboj, Sunjeev K., et al.
Publicado: (2017)

Substance-induced anxiety disorder after one dose of 3,4-methylenedioxymethamphetamine: a case report
por: Kaplan, Kaeley, et al.
Publicado: (2018)

Extracorporeal Membrane Oxygenation Support in Refractory Multi-organ Failure by 3,4-Methylenedioxymethamphetamine Intoxication (“Ecstasy”)
por: Ruiz, Victoria, et al.
Publicado: (2022)

Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects
por: Vizeli, Patrick, et al.
Publicado: (2022)

Early onset Parkinson’s disease in the cycle of 3,4-methylenedioxymethamphetamine and substance use: a case report
por: Hui, Tianyi, et al.
Publicado: (2023)

Cardiac effects of ephedrine, norephedrine, mescaline, and 3,4-methylenedioxymethamphetamine (MDMA) in mouse and human atrial preparations
por: Neumann, Joachim, et al.
Publicado: (2022)

Ubiquitination of Neurotransmitter Receptors and Postsynaptic Scaffolding Proteins
por: Lin, Amy W., et al.
Publicado: (2013)

Ultrasonic Communication in Rats: Can Playback of 50-kHz Calls Induce Approach Behavior?
por: Wöhr, Markus, et al.
Publicado: (2007)

Rapidly reversible multiorgan failure after ingestion of “Molly” (pure 3,4-methylenedioxymethamphetamine): a case report
por: Vakde, Trupti, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q9q5psdealm3t10fg7j9gtka2p